“  Effectiveness and safety of Lanadelumab according to disease activity: pooled analysis of EMPOWER/ENABLE ”, Rev Alerg Mex, vol. 72, no. 3, pp. 221–222, Sep. 2025, doi: 10.29262/ram.v72i3.1505.